Influence of Disease Site and Activity on Peripheral Neutrophil Function in Inflammatory Bowel Disease

Digestive Diseases and Sciences - Tập 45 - Trang 1594-1600 - 2000
Anna D'odorico1, Renata D'inca1, Cinzia Mestriner1, Vincenza Di Leo1, Antonio Ferronato1, Giacomo carlo Sturniolo1
1Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Universit`a di Padova, Padua, Italy

Tóm tắt

Reactive oxygen species, released by phagocytes, are involved in tissue injury in inflammatory bowel diseases. The aim of our study was to evaluate peripheral neutrophil function in patients with ulcerative colitis (N = 66) and Crohn's disease (N = 62) with respect to disease activity and extent, using chemiluminometry after three stimuli. Twenty-seven healthy subjects were enrolled as controls. Neutrophils from ulcerative colitis and Crohn's disease patients had a significantly higher response than those from controls following phorbol myristate acetate (86.6 ± 6.5, 173.8 ± 11.9, 167.5 ± 12.2 mV, P < 0.0001), formyl-methionyl-leucyl-phenylalanine (39.5 ± 3.4, 41.3 ± 2.7, 58.6 ± 4.7 mV, P < 0.001), and zymosan (142.6 ± 10.4, 223.7 ± 8.9, 231.2 ± 9.5 mV, P < 0.0001) administration. The increased response was observed during both active disease and remission. The highest chemiluminescence values were found in patients with active ulcerative pancolitis and ileal Crohn's disease. The activation of circulating neutrophils may indicate persistent intestinal inflammation or may be triggered by luminal factors even in the absence of symptoms.

Tài liệu tham khảo

Riddel RH: Pathology of idiopathic inflammatory bowel disease. In JB Kirsner, RG Shorter (eds). Inflammatory Bowel Disease. Philadelphia, Lea and Febiger 1988, pp 329–350 Grisham MB, Granger DN: Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 33(suppl):6s-15s, 1988 Allgayer H: Clinical relevance of oxygen radicals in inflammatory bowel disease-facts and fashion. Klin Wochenschr 69:1001–1003, 1991 Nielsen OH, Ahnfelt-Ronne I: Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 69:995–1000, 1991 Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M: Active oxygen species generated by monocytes and polymorphonuclear leukocytes in Crohn' disease. Dig Dis Sci 33:951–955, 1988 Kashavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C and Winship D: Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology 103:177–185, 1992 Carter I, Wallace JL: Alteration in rat peripheral blood neutrophil function as a consequence of colitis. Dig Dis Sci 40(1):192–197, 1995 Sedghi S, Fields JZ, Klamut M, Urban G, Durkin M, Winship D, Fretland D, Olyaee M, Keshavarzian A: Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut 34:1191–1197, 1993 Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M: Role of reactive oxygen metabolites in experimental colitis. Gut 31:786–790, 1990 Haydek JM, Keshavarzian A: Circulating neutrophils from patients with ulcerative colitis have a normal respiratory burst. Inflammation 19(6):701–715, 1995 Kelleher D, Feighery C, Weir DG: Chemiluminescence by polymorphonuclear leukocyte subpopulations in chronic inflammatory bowel disease. Digestion 45:158–165, 1990 Curran FT, Allan RN, Keighley MRB: Superoxide production by Crohn' disease neutrophils. Gut 32:399–402, 1991 Powell-Tuck J, Day DW, Backell NA, Wadsworth J, Lennard-Jones JE: Correlation between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 27:533–537, 1982 Best WR, Becktel JM, Singleton JW: Rederived values of the eight coefficients of the Crohn' disease activity index (CDAI). Gastroenterology 77:843–846, 1979 Galvani DW, Nethersell A, Cawley JC: The beneficial effects of interferon in CGL are probably not mediated by NK cells. Br J Hemat 71:233–237, 1989 Edwards SW: Luminol and lucigenin-dependent chemiluminescence of neutrophils: Role of degranulation. J Clin Lab Immunol 22:35–39, 1987 Follin P, Briheim G, Sandstedt S, Dahlgren C: Human neutrophil chemiluminescence and f-Meth-Leu-Phe receptor exposure in bacterial infections. APMIS 97:585–590, 1989 Lundqvist H, Follin P, Khalfan L, Dahlgren C: Phorbol myristate acetate-induced NADPH oxidase activity in human neutrophils: Only half the story has been told. J Leukoc Biol 59:270–279, 1996 Roos D: The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages. Klin Wochenschr 69:975–980, 1991 Kazi N, Fields JZ, Sedghi S, Kottapalli V, Eiznhamer D, Winship D, Keshavarzian A: Modulation of neutrophil function by novel colonic factors: Possible role in the pathophysiology of ulcerative colitis. J Lab Clin Med 126:70–80, 1995 Bender JG, Van Epps DE, Chenoweth DE: Indipendent regulation of human neutrophil chemotactic receptors after activation. J Immunol 139:3028–3033, 1987 Fletcher M, Gallin J: Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine. Blood 62:792–799, 1983 Bengtsson T, Dahlgren C, Stendahl O, Andersson T: Actin assembly and regulation of neutrophil function: Effects of cytochalasin B and tetracaine on chemotactic peptide-induced O2 - production and degranulation. J Leukoc Biol 49:236–244, 1991 Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne JF, Florent C, Bouvry M, Mary JY, Modigliani R: Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn' disease. A prospective multicentre study of 121 cases. Gut 35(2):231–235, 1994 Verpaget HW, Mieremet-Doms MAC, Weterman IT, Pena AS: Partial defect of neutrophils oxidative metabolism in Crohn' disease. Gut 25:849–853, 1984 Verpaget HW, Elmgreen J, Weterman IT, Pena AS, Riis P, Lamers CBHW: Impaired activation of the neutrophils oxidative metabolism in chronic inflammatory bowel disease. Scand J Gastroenterol 21:1124–1130, 1986 Verpaget HW, Pena AS, Weterman IT, Lamers CBHW: Diminished neutrophil function in Crohn' disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 29:223–228, 1988 Gionchetti P, Campieri M, Guarnieri C, Belluzzi A, Brignola C, Bertinelli E, Ferretti M, Miglioli M, Barbara L: Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission. Dig Dis Sci 39:550–554, 1994 Williams JG, Hughes LE, Hallett MB: Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 31:187–193, 1990 Skubitz KM, Hammerschmidt DE: Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitation and receptor downregulation. Blood 68(4):830–836, 1986 Carlin G, Djursater R, Smedegard G: Inhibitory effects of sulfasalazine and related compounds on superoxide production by human polymorphonuclear leukocytes. Pharmacol Toxicol 65: 121–127 Verspaget HW, Aparicio-Pages MN, Verver S, Edelbroek PM, Hafkenscheid JCM, Cramabohbouth GE, Pena AS, Weterman IT, Lamers CBHW: Influence of sulhasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Scand J Gastroenterol 26:779–786, 1991 Faden H, Rossi TM: Chemiluminescent response of neutrophils from patients with inflammatory bowel disease. Dig Dis Sci 28:236–248, 1983 Shiratora Y, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K, Teraoka H, Matano S, Matsumoto K, Kamii K: Oxygenderived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 44:163–171, 1989 Boyum A: Isolation of leukocytes. Scand J Clin Lab Invest 21(suppl 97):9–109, 1968 Suematsu M, Suzuki M, Kitahora S, Miura S, Suzuki K, Hibi T, Watanabe M, Nagata H, Asakura H, Tsuchiya M: Increased respiratory burst of leukocytes in inflammatory bowel diseases. The analysis of free radical generation by using chemiluminescence probe. J Clin Lab Immunol 24:125–128, 1987